ICAD Icad Inc
Price (delayed)
$1.61
Market cap
$42.73M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.09
Enterprise value
$22.85M
iCAD Inc., headquartered in Nashua, New Hampshire, is a medical-device manufacturer. iCAD makes cancer detection and radiation therapy devices. iCAD offers computer aided detection and workflow solutions to support detection
Highlights
The debt has plunged by 85% YoY and by 10% from the previous quarter
The net income has soared by 82% YoY
Icad's quick ratio has soared by 88% YoY but it has decreased by 10% from the previous quarter
The equity has contracted by 4.6% from the previous quarter but it has grown by 2.6% YoY
Key stats
What are the main financial stats of ICAD
Market
Valuations
Earnings
Shares outstanding
26.54M
Market cap
$42.73M
Enterprise value
$22.85M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.38
Price to sales (P/S)
2.26
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.22
Revenue
$18.8M
EBIT
-$2.24M
EBITDA
-$1.46M
Free cash flow
-$5.27M
Per share
Balance sheet
Liquidity
EPS
-$0.09
Free cash flow per share
-$0.2
Book value per share
$1.17
Revenue per share
$0.71
TBVPS
$1.16
Total assets
$38.94M
Total liabilities
$7.98M
Debt
$469,000
Equity
$30.96M
Working capital
$21.26M
Debt to equity
0.02
Current ratio
4.24
Quick ratio
3.92
Net debt/EBITDA
13.62
Margins
Efficiency
Dividend
EBITDA margin
-7.8%
Gross margin
86%
Net margin
-12.1%
Operating margin
-28.3%
Return on assets
-5.5%
Return on equity
-7.1%
Return on invested capital
-40.3%
Return on capital employed
-6.9%
Return on sales
-11.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ICAD stock price
How has the Icad stock price performed over time
Intraday
-1.83%
1 week
15%
1 month
-4.17%
1 year
-19.1%
YTD
-9.04%
QTD
23.85%
Financial performance
How have Icad's revenue and profit performed over time
Revenue
$18.8M
Gross profit
$16.17M
Operating income
-$5.33M
Net income
-$2.28M
Gross margin
86%
Net margin
-12.1%
The net margin has soared by 83% YoY and by 5% from the previous quarter
The net income has soared by 82% YoY
The operating margin has soared by 57% year-on-year and by 14% since the previous quarter
Icad's operating income has soared by 54% YoY and by 10% from the previous quarter
Growth
What is Icad's growth rate over time
Valuation
What is Icad stock price valuation
P/E
N/A
P/B
1.38
P/S
2.26
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.22
The company's EPS has surged by 82% YoY
ICAD's price to book (P/B) is 78% lower than its 5-year quarterly average of 6.3
The equity has contracted by 4.6% from the previous quarter but it has grown by 2.6% YoY
ICAD's P/S is 56% below its 5-year quarterly average of 5.2 and 8% below its last 4 quarters average of 2.5
ICAD's revenue is up by 7% YoY and by 4.8% QoQ
Efficiency
How efficient is Icad business performance
The company's return on sales has surged by 83% YoY and by 6% QoQ
The ROE has soared by 81% YoY
Icad's return on assets has surged by 78% YoY but it has decreased by 3.8% QoQ
ICAD's return on invested capital has surged by 71% year-on-year but it is down by 19% since the previous quarter
Dividends
What is ICAD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ICAD.
Financial health
How did Icad financials performed over time
Icad's quick ratio has soared by 88% YoY but it has decreased by 10% from the previous quarter
The current ratio has soared by 61% YoY but it has contracted by 10% from the previous quarter
The debt is 98% less than the equity
The debt has plunged by 85% YoY and by 10% from the previous quarter
The debt to equity has dropped by 80% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.